IL138809A0 - Fusion proteins of mycobacterium tuberculosis antigens and pharmaceutical compositions containing the same - Google Patents
Fusion proteins of mycobacterium tuberculosis antigens and pharmaceutical compositions containing the sameInfo
- Publication number
- IL138809A0 IL138809A0 IL13880999A IL13880999A IL138809A0 IL 138809 A0 IL138809 A0 IL 138809A0 IL 13880999 A IL13880999 A IL 13880999A IL 13880999 A IL13880999 A IL 13880999A IL 138809 A0 IL138809 A0 IL 138809A0
- Authority
- IL
- Israel
- Prior art keywords
- same
- pharmaceutical compositions
- fusion proteins
- compositions containing
- mycobacterium tuberculosis
- Prior art date
Links
- 241000187479 Mycobacterium tuberculosis Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/056,556 US6350456B1 (en) | 1997-03-13 | 1998-04-07 | Compositions and methods for the prevention and treatment of M. tuberculosis infection |
US09/223,040 US6544522B1 (en) | 1998-12-30 | 1998-12-30 | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
PCT/US1999/007717 WO1999051748A2 (en) | 1998-04-07 | 1999-04-07 | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
IL138809A0 true IL138809A0 (en) | 2001-10-31 |
Family
ID=26735428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13880999A IL138809A0 (en) | 1998-04-07 | 1999-04-07 | Fusion proteins of mycobacterium tuberculosis antigens and pharmaceutical compositions containing the same |
Country Status (17)
Country | Link |
---|---|
US (2) | US7186412B1 (xx) |
EP (1) | EP1068329A2 (xx) |
JP (2) | JP4227302B2 (xx) |
KR (2) | KR100797876B1 (xx) |
CN (2) | CN1163602C (xx) |
AU (1) | AU753995B2 (xx) |
BR (1) | BR9909472A (xx) |
CA (1) | CA2326598C (xx) |
CZ (1) | CZ302870B6 (xx) |
HU (1) | HU228354B1 (xx) |
IL (1) | IL138809A0 (xx) |
NO (2) | NO332500B1 (xx) |
NZ (1) | NZ507378A (xx) |
PL (1) | PL202844B1 (xx) |
SA (1) | SA99200488B1 (xx) |
TR (1) | TR200002938T2 (xx) |
WO (1) | WO1999051748A2 (xx) |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6290969B1 (en) * | 1995-09-01 | 2001-09-18 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
US6592877B1 (en) * | 1995-09-01 | 2003-07-15 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
US6458366B1 (en) | 1995-09-01 | 2002-10-01 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
BR9909472A (pt) | 1998-04-07 | 2001-09-11 | Corixa Corp | Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica |
ATE445638T1 (de) * | 1998-11-04 | 2009-10-15 | Isis Innovation | Tuberkulose diagnose test |
US6447779B1 (en) | 1998-12-08 | 2002-09-10 | Corixa Corporation | Compounds for the diagnosis of Chlamydial infection |
US6555115B1 (en) | 1998-12-08 | 2003-04-29 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
US6432916B1 (en) | 1998-12-08 | 2002-08-13 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
US6448234B1 (en) | 1998-12-08 | 2002-09-10 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
US6565856B1 (en) * | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
US7083796B2 (en) * | 2000-06-20 | 2006-08-01 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
US20030027774A1 (en) * | 1999-03-18 | 2003-02-06 | Ronald C. Hendrickson | Tuberculosis antigens and methods of use therefor |
US8143386B2 (en) * | 1999-04-07 | 2012-03-27 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
WO2001024820A1 (en) * | 1999-10-07 | 2001-04-12 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
US7009042B1 (en) | 1999-10-07 | 2006-03-07 | Corixa Corporation | Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins |
DE60033583T2 (de) * | 1999-10-07 | 2007-09-13 | Corixa Corp. CSC, Wilmington | Eine mycobacterium tuberculosis kodierende sequenz zur expression von heterologen proteinen |
US6316205B1 (en) | 2000-01-28 | 2001-11-13 | Genelabs Diagnostics Pte Ltd. | Assay devices and methods of analyte detection |
WO2001062893A2 (en) * | 2000-02-25 | 2001-08-30 | Corixa Corporation | Compounds and methods for diagnosis and immunotherapy of tuberculosis |
GB0006692D0 (en) * | 2000-03-20 | 2000-05-10 | Glaxo Group Ltd | Epitopes |
EP1278855B1 (en) | 2000-04-21 | 2008-03-12 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
US6919187B2 (en) | 2000-04-21 | 2005-07-19 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
GB0109297D0 (en) | 2001-04-12 | 2001-05-30 | Glaxosmithkline Biolog Sa | Vaccine |
US6841159B2 (en) | 2002-01-30 | 2005-01-11 | The United States Of America As Represented By The Secretary Of The Navy | Rapid lateral flow assay for determining exposure to Mycobacterium tuberculosis and other mycobacteria |
WO2003070187A2 (en) | 2002-02-15 | 2003-08-28 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
GB0321615D0 (en) | 2003-09-15 | 2003-10-15 | Glaxo Group Ltd | Improvements in vaccination |
WO2005061534A2 (en) * | 2003-12-23 | 2005-07-07 | Statens Serum Institut | Improved tuberculosis vaccines |
US8475735B2 (en) | 2004-11-01 | 2013-07-02 | Uma Mahesh Babu | Disposable immunodiagnostic test system |
BRPI0518933A2 (pt) | 2004-11-16 | 2008-12-16 | Crucell Holland B V E Aeras Gl | adenovÍrus recombinante defeituoso de replicaÇço, vetor de polinucleotÍdeo recombinante, vacina multivalente da tuberculose, e, uso do antÍgeno tb10.4 de mycobacterium |
CN100368437C (zh) * | 2005-01-28 | 2008-02-13 | 中国农业科学院哈尔滨兽医研究所 | 一种诊断牛结核病的重组抗原蛋白及其制备方法 |
SI2457926T1 (sl) | 2005-04-29 | 2015-01-30 | Glaxosmithkline Biologicals S.A. | Nov postopek za preprečevanje ali zdravljenje infekcije z M. tuberculosis |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
CN100999550B (zh) * | 2006-01-10 | 2010-10-06 | 中国人民解放军第三○九医院 | 结核分枝杆菌融合蛋白及其应用 |
CN101311190B (zh) * | 2006-06-06 | 2011-08-03 | 中国人民解放军第二军医大学 | 激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途 |
CN101311189B (zh) * | 2006-06-06 | 2010-09-08 | 中国人民解放军第二军医大学 | 激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途 |
CN100415771C (zh) * | 2006-06-06 | 2008-09-03 | 中国人民解放军第二军医大学 | 激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途 |
CN101298471B (zh) * | 2006-06-06 | 2011-01-19 | 中国人民解放军第二军医大学 | 激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途 |
JP5165681B2 (ja) * | 2006-06-28 | 2013-03-21 | ステイテンス・セラム・インスティテュート | タンパク質断片又はペプチドカクテルとして送達される抗原を用いたワクチン接種によるサブドミナントエピトープを含むt細胞レパートリーの拡大 |
US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
ES2657392T3 (es) | 2006-09-26 | 2018-03-05 | Infectious Disease Research Institute | Composición de vacuna que contiene un adyuvante sintético |
EP2433648A3 (en) | 2006-10-12 | 2012-04-04 | GlaxoSmithKline Biologicals S.A. | Vaccine comprising an oil in water emulsion adjuvant |
WO2008043774A1 (en) | 2006-10-12 | 2008-04-17 | Glaxosmithkline Biologicals S.A. | Vaccine comprising an oil in water emulsion adjuvant |
CN101675068A (zh) | 2007-03-02 | 2010-03-17 | 葛兰素史密丝克莱恩生物有限公司 | 新的方法和组合物 |
US9717788B2 (en) | 2007-03-02 | 2017-08-01 | Glaxosmithkline Biologicals Sa | Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant |
MX351247B (es) * | 2007-04-04 | 2017-10-05 | Infectious Disease Res Institute Star | Composiciones inmunogenicas que comprenden polipeptidos de mycobacterium tuberculosis y fusiones de los mismos. |
PL2200641T3 (pl) * | 2007-10-13 | 2012-12-31 | Univ Cornell | Kompozycje do wywoływania odpowiedzi immunologicznej skierowanej przeciw Mycobacterium avium podgatunkowi paratuberculosis |
KR101378240B1 (ko) | 2008-02-22 | 2014-03-28 | 포항공과대학교 산학협력단 | 결핵 예방용 조성물 |
AU2010222929B2 (en) | 2008-07-16 | 2013-07-25 | Baylor Research Institute | Antigen presenting cell targeted anti-viral vaccines |
CN102164952B (zh) * | 2008-07-25 | 2016-05-25 | 葛兰素史密丝克莱恩生物有限公司 | 新型组合物和方法 |
EA022203B1 (ru) | 2008-07-25 | 2015-11-30 | Глаксосмитклайн Байолоджикалс С.А. | Способы и композиции для лечения или предупреждения туберкулёза |
PL2315834T3 (pl) | 2008-07-25 | 2018-12-31 | Glaxosmithkline Biologicals S.A. | Białko rv2386c związane z gruźlicą, jego kompozycje i zastosowania |
GB0815872D0 (en) | 2008-09-01 | 2008-10-08 | Pasteur Institut | Novel method and compositions |
AU2010222942B2 (en) | 2009-03-10 | 2013-01-10 | Baylor Research Institute | Anti-CD40 antibodies and uses thereof |
CA2754743C (en) | 2009-03-10 | 2020-08-25 | Baylor Research Institute | Antigen presenting cell targeted anti-viral vaccines |
PT2437753T (pt) | 2009-06-05 | 2016-11-23 | Infectious Disease Res Inst | Adjuvantes lipídicos de glucopiranosilo sintéticos e composições de vacina contendo os mesmos |
SG182573A1 (en) | 2010-01-27 | 2012-08-30 | Glaxosmithkline Biolog Sa | Modified tuberculosis antigens |
EP2544693B1 (en) | 2010-03-09 | 2017-09-13 | Biomedical Research Models, Inc. | A novel mucosal vaccination approach for herpes simplex virus type-2 |
ME02380B (me) | 2010-12-14 | 2016-06-20 | Glaxosmithkline Biologicals Sa | Mikobakterijska antigena kompozicija |
GB201022007D0 (en) | 2010-12-24 | 2011-02-02 | Imp Innovations Ltd | DNA-sensor |
CN102154324B (zh) * | 2010-12-29 | 2012-11-28 | 兰州大学 | 结核分枝杆菌融合蛋白Mtb10.4-Hsp16.3的构建、表达和纯化方法及其应用 |
AR085573A1 (es) | 2011-03-25 | 2013-10-09 | Baylor Res Inst | Composiciones y metodos de inmunizacion contra el virus de la hepatitis c |
MX350795B (es) | 2011-04-08 | 2017-09-19 | Inmune Design Corp | Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares. |
US20120288515A1 (en) | 2011-04-27 | 2012-11-15 | Immune Design Corp. | Synthetic long peptide (slp)-based vaccines |
CN102305855A (zh) * | 2011-05-19 | 2012-01-04 | 中山大学 | 体外检测结核分枝杆菌感染的试剂和方法 |
EP2771469A4 (en) * | 2011-10-24 | 2015-04-08 | Univ Central Florida Res Found | ANTIGENS ESAT-6 AND MTB72F VACCINES AGAINST MYCOBACTERIUM TUBERCULOSIS EXPRESSED BY PLASTS AND FUSIONED AT SUBUNIT B OF CHOLERA TOXIN |
LT2811981T (lt) | 2012-02-07 | 2019-06-10 | Infectious Disease Research Institute | Pagerintos adjuvanto kompozicijos, apimančios tlr4 agonistus, ir jų panaudojimo būdai |
MX347154B (es) | 2012-02-24 | 2017-02-21 | Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese) | Prueba de diagnóstico para enfermedades infecciosas en ganado bovino. |
LT2850431T (lt) | 2012-05-16 | 2018-06-25 | Immune Design Corp. | Vakcinos, skirtos hsv-2 |
CN102757971B (zh) * | 2012-08-07 | 2013-09-11 | 中国人民解放军第三O九医院 | 一种结核分枝杆菌重组蛋白质及其制备方法 |
IN2015DN03962A (xx) * | 2012-10-23 | 2015-10-02 | Statens Seruminstitut | |
WO2014107731A1 (en) | 2013-01-07 | 2014-07-10 | Biomedical Research Models, Inc. | Therapeutic vaccines for treating herpes simplex virus type 2 infections |
AU2014232335C1 (en) | 2013-03-15 | 2016-09-01 | The Trustees Of The University Of Pennsylvania | Synthetic immunogens for prophylaxis or treatment of tuberculosis |
JP6426706B2 (ja) | 2013-04-18 | 2018-11-21 | イミューン デザイン コーポレイション | がん処置で使用するためのgla単剤療法 |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
KR102411781B1 (ko) | 2013-12-31 | 2022-06-22 | 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) | 단일 바이알 백신 제형 |
EP3094652B1 (en) | 2014-01-13 | 2021-09-29 | Baylor Research Institute | Novel vaccines against hpv and hpv-related diseases |
US20190062400A1 (en) * | 2016-03-02 | 2019-02-28 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
WO2017176076A1 (en) | 2016-04-06 | 2017-10-12 | Ewha University - Industry Collaboration Foundation | A peptide with ability to penetrate cell membrane |
DK3458475T3 (da) | 2016-05-16 | 2022-09-12 | Access To Advanced Health Inst | Formulering, der indeholder tlr-agonist, og anvendelsesfremgangsmåder |
JP7195147B2 (ja) | 2016-05-16 | 2022-12-23 | アクセス ツー アドバンスト ヘルス インスティチュート | Peg化リポソームおよび使用方法 |
IL298227B2 (en) | 2016-06-01 | 2024-09-01 | Access To Advanced Health Inst | Nanoalum particles containing a fixing factor |
JP2020524143A (ja) | 2017-06-15 | 2020-08-13 | インフェクシャス ディズィーズ リサーチ インスティチュート | ナノ構造脂質担体、安定エマルジョン、およびその使用 |
EP3678695A1 (en) | 2017-09-08 | 2020-07-15 | Infectious Disease Research Institute | Liposomal formulations comprising saponin and methods of use |
US10610585B2 (en) | 2017-09-26 | 2020-04-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and compositions for treating and preventing HIV |
CN109825497A (zh) * | 2019-01-25 | 2019-05-31 | 石河子大学 | 一种新型结核杆菌融合菌株的制备方法及其应用 |
JP2022532944A (ja) | 2019-05-25 | 2022-07-20 | アクセス ツー アドバンスト ヘルス インスティチュート | アジュバントワクチンエマルジョンを噴霧乾燥するための組成物および方法 |
WO2024052882A1 (en) | 2022-09-09 | 2024-03-14 | Access To Advanced Health Institute | Immunogenic vaccine composition incorporating a saponin |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
US6024983A (en) | 1986-10-24 | 2000-02-15 | Southern Research Institute | Composition for delivering bioactive agents for immune response and its preparation |
US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
EP0471036B2 (en) | 1989-05-04 | 2004-06-23 | Southern Research Institute | Encapsulation process |
EP0553235A1 (en) | 1990-10-01 | 1993-08-04 | The University Of Connecticut | Targeting viruses and cells for selective internalization by cells |
AU668870B2 (en) | 1991-05-14 | 1996-05-23 | Targetech, Inc | Targeted delivery of genes encoding immunogenic proteins |
AU2160992A (en) | 1991-06-05 | 1993-01-12 | Board Of Regents Acting For And On Behalf Of The University Of Michigan, The | Targeted delivery of genes encoding secretory proteins |
ES2140400T3 (es) * | 1991-08-15 | 2000-03-01 | Hoffmann La Roche | Cebadores y sondas del micobacterium. |
WO1993014188A1 (en) | 1992-01-17 | 1993-07-22 | The Regents Of The University Of Michigan | Targeted virus |
EP0633943A4 (en) | 1992-04-03 | 1997-05-02 | Alexander T Young | GENTHERAPY USING TARGETED VIRAL VECTORS. |
UA40597C2 (uk) | 1992-06-25 | 2001-08-15 | Смітклайн Бічем Байолоджікалс С.А. | Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів |
US5330754A (en) * | 1992-06-29 | 1994-07-19 | Archana Kapoor | Membrane-associated immunogens of mycobacteria |
US5359681A (en) | 1993-01-11 | 1994-10-25 | University Of Washington | Fiber optic sensor and methods and apparatus relating thereto |
US5955077A (en) | 1993-07-02 | 1999-09-21 | Statens Seruminstitut | Tuberculosis vaccine |
DK79893D0 (da) * | 1993-07-02 | 1993-07-02 | Statens Seruminstitut | New vaccine |
DK79793D0 (da) * | 1993-07-02 | 1993-07-02 | Statens Seruminstitut | Diagnostic test |
US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
PT2154248E (pt) * | 1995-09-01 | 2012-01-16 | Corixa Corp | Compostos e métodos para diagnóstico de tuberculose |
HU227778B1 (en) * | 1995-09-01 | 2012-02-28 | Corixa Corp | Immogen peptid of m. tuberculosis origin, therapeutic and diagnostic use thereof |
US6544522B1 (en) * | 1998-12-30 | 2003-04-08 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
US6627198B2 (en) * | 1997-03-13 | 2003-09-30 | Corixa Corporation | Fusion proteins of Mycobacterium tuberculosis antigens and their uses |
BR9909472A (pt) | 1998-04-07 | 2001-09-11 | Corixa Corp | Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica |
-
1999
- 1999-04-07 BR BR9909472-0A patent/BR9909472A/pt not_active Application Discontinuation
- 1999-04-07 CN CNB998070777A patent/CN1163602C/zh not_active Expired - Fee Related
- 1999-04-07 HU HU0101521A patent/HU228354B1/hu not_active IP Right Cessation
- 1999-04-07 CZ CZ20003652A patent/CZ302870B6/cs not_active IP Right Cessation
- 1999-04-07 EP EP99916513A patent/EP1068329A2/en not_active Withdrawn
- 1999-04-07 KR KR1020067009456A patent/KR100797876B1/ko not_active IP Right Cessation
- 1999-04-07 AU AU34817/99A patent/AU753995B2/en not_active Ceased
- 1999-04-07 CN CN2004100618462A patent/CN1629185B/zh not_active Expired - Fee Related
- 1999-04-07 TR TR2000/02938T patent/TR200002938T2/xx unknown
- 1999-04-07 KR KR1020007011196A patent/KR100692227B1/ko not_active IP Right Cessation
- 1999-04-07 CA CA2326598A patent/CA2326598C/en not_active Expired - Fee Related
- 1999-04-07 NZ NZ507378A patent/NZ507378A/xx unknown
- 1999-04-07 WO PCT/US1999/007717 patent/WO1999051748A2/en active Search and Examination
- 1999-04-07 PL PL344142A patent/PL202844B1/pl not_active IP Right Cessation
- 1999-04-07 JP JP2000542460A patent/JP4227302B2/ja not_active Expired - Fee Related
- 1999-04-07 IL IL13880999A patent/IL138809A0/xx unknown
- 1999-08-17 SA SA99200488A patent/SA99200488B1/ar unknown
-
2000
- 2000-06-20 US US09/597,796 patent/US7186412B1/en not_active Expired - Fee Related
- 2000-10-06 NO NO20005050A patent/NO332500B1/no not_active IP Right Cessation
-
2006
- 2006-03-30 US US11/396,117 patent/US7261897B2/en not_active Expired - Fee Related
- 2006-03-31 JP JP2006100968A patent/JP4326008B2/ja not_active Expired - Fee Related
-
2012
- 2012-05-25 NO NO20120621A patent/NO20120621L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL138809A0 (en) | Fusion proteins of mycobacterium tuberculosis antigens and pharmaceutical compositions containing the same | |
IL136251A0 (en) | Soft pellet drug composition and methods for the preparation thereof | |
HUP9701554D0 (en) | Pharmaceutical composition containing plazma proteins | |
HUP0004398A3 (en) | Alpha-aryl-n-alkylnitrones and pharmaceutical compositions containing the same | |
IL119995A0 (en) | Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them | |
IL121936A0 (en) | Polypeptides containing a tuberculosis antigen compositions containing the same and methods for diagnosis of tuberculosis utilizing the same | |
IL121236A0 (en) | Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them | |
HUP0100949A3 (en) | Aryl fused azapolycyclic compounds and pharmaceutical compositions containing the same | |
HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
IL115484A0 (en) | Polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL130396A0 (en) | OB fusion protein compositions and methods | |
IL136938A0 (en) | 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
IL131319A0 (en) | 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same | |
IL121235A0 (en) | Bicyclic-fused pyridines their preparation and pharmaceutical compositions containing them | |
EP1229931A4 (en) | FUSION PROTEINS FROM MYCOBACTERIUM TUBERCULOSIS | |
IL133097A0 (en) | Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof | |
PL337667A1 (en) | Superficially acting antigens and proteins useful in diagnostic compositions and in preventing lymean borreliosis | |
HUP0100470A3 (en) | Oxazolidinone derivatives and pharmaceutical compositions containing them | |
GB9710800D0 (en) | Pharmaceutical composition and method of preparing it | |
HUP0100085A3 (en) | Biphenylamidine derivatives and pharmaceutical compositions containing them | |
IL131846A0 (en) | Novel pyridine derivatives and pharmaceutical compositions containing them | |
EP0968983A4 (en) | COMPOSITION BASED ON HEXANITROHEXAAZAISOWURTIZITAN AND HEXANITROHEXAAZAISOWURTIZITAN COMPOSITION OF EXPLOSIVES | |
IL115272A0 (en) | Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof | |
HUP0003330A3 (en) | Pharmaceutical compositions containing tizoxanide and nitazoxanide | |
IL136045A0 (en) | Pyridylpyrrole derivatives and pharmaceutical compositions containing the same |